Cite
MLA Citation
Kazuhiko Nakagawa et al.. “Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.” Lancet oncology, vol. 20, no. 12, 2019, pp. 1655–1669. http://access.bl.uk/ark:/81055/vdc_100141197735.0x00001b